Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2012 Jul;19(7):2360-6.
doi: 10.1245/s10434-011-2213-2. Epub 2012 Jan 21.

Merkel cell carcinoma of unknown primary origin

Affiliations
Clinical Trial

Merkel cell carcinoma of unknown primary origin

Jeremiah L Deneve et al. Ann Surg Oncol. 2012 Jul.

Abstract

Background: Merkel cell carcinoma (MCC) is a rare neuroendocrine tumor of the skin. MCC from an unknown primary origin (MCCUP) can present a diagnostic and therapeutic challenge. We describe our single-institution experience with the diagnosis and management of MCCUP presenting as metastases to lymph nodes.

Methods: After institutional review board approval, our institutional database spanning the years 1998-2010 was queried for patients with MCCUP. Clinicopathologic variables and outcomes were assessed.

Results: From a database of 321 patients with MCC, 38 (12%) were identified as having nodal MCCUP. Median age was 67 years, and 79% were men. Nodal basins involved at presentation were cervical (58%), axillary/epitrochlear (21%), or inguinal/iliac (21%). CK20 staining was positive in 93% of tumors tested, and all were negative for thyroid transcription factor-1. Twenty-nine patients (76%) underwent complete regional lymph node dissection (LND): 3 had LND alone, ten had LND and adjuvant radiotherapy, and 16 underwent LND followed by chemoradiotherapy. Definitive chemoradiotherapy without surgery was provided to six patients (16%), while radiotherapy alone was provided to three (8%). Recurrence was observed in 34% of patients. Median recurrence-free survival was 35 months. Ten patients (26%) died, five of disease and five of other causes. The median overall survival was 104 months.

Conclusions: Nodal MCCUP is a rare disease affecting primarily elderly white men. Recurrence is observed in approximately one-third of patients, with a 104 month median overall survival after a multimodal treatment approach consisting of surgery along with adjuvant chemotherapy and radiotherapy in the majority of patients.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Immunohistochemical staining features of all patients with Merkel cell carcinoma of unknown primary origin
FIG. 2
FIG. 2
a Recurrence-free survival (RFS) for all patients treated for Merkel cell carcinoma (MCC) of unknown primary origin. b RFS based on treatment for all patients treated for MCC of unknown primary origin
FIG. 3
FIG. 3
a Overall survival (OS) for all patients treated for Merkel cell carcinoma (MCC) of unknown primary origin. b OS based on treatment for all patients treated for MCC of unknown primary origin

Similar articles

Cited by

References

    1. Hodgson NC. Merkel cell carcinoma: changing incidence trends. J Surg Oncol. 2005;89:1–4. - PubMed
    1. Pan D, Narayan D, Ariyan S. Merkel cell carcinoma: five case reports using sentinel lymph node biopsy and a review of 110 new cases. Plast Reconstr Surg. 2002;110:1259–1265. - PubMed
    1. Koljonen V. Merkel cell carcinoma. World J Surg Oncol. 2006;4:7. - PMC - PubMed
    1. Lemos B, Nghiem P. Merkel cell carcinoma: more deaths but still no pathway to blame. J Invest Dermatol. 2007;127:2100–2103. - PubMed
    1. Edge SB, editor. Merkel cell carcinoma. AJCC cancer staging manual. 7th ed. New York: Springer; 2010. pp. 315–323.

Publication types

MeSH terms

LinkOut - more resources